Brett Guthrie will reform the health care system.

My priorities include ... reforming the health care system

Guthrie commits to changes in health care policy and administration.

Brett Guthrie Files for Re-Election to U.S. House of Representatives - Brett Guthrie for Congress
campaign · press_release · model gpt-5.4-mini

In this position, he leads the fight for lower costs in health care and keeping the government out of the doctor-patient relationship.

The page says Guthrie is leading efforts to lower health care costs and reduce government involvement in medical decisions.

Meet Brett | Brett Guthrie for Congress
campaign · campaign_site · model gpt-5.4-mini

On June 16, Guthrie and other E&C leaders asked NIH for details about alleged illegal transport of biological materials and requested a written response by June 30.

This is concrete health-related oversight activity in Guthrie's role, but it does not show that he has actually reformed the health care system.

unresolved same_term A for effort

House Committee on Energy and Commerce
secondary · model gpt-5.4-mini · confidence 71%

The Health Subcommittee held a hearing on health care transparency and discussed an updated Lower Costs, More Transparency Act plus prior-authorization data requirements.

Guthrie's committee is actively pursuing health care reform ideas, but this was still a hearing and proposal stage, not enacted system-wide reform.

unresolved same_term A for effort

House Committee on Energy and Commerce
secondary · model gpt-5.4-mini · confidence 86%

The House vote on H.R. 3590, the Patient Protection and Affordable Care Act, passed 219-212. The Clerk lists Brett Guthrie, Republican of Kentucky, voting No.

A major federal health care reform was enacted during Guthrie's first House term, but he voted against it, so it does not show that he delivered his own promised reform.

never same_term

Office of the Clerk, U.S. House of Representatives - Roll Call 165, H.R. 3590 Patient Protection and Affordable Care Act
secondary · model gpt-5.5 · confidence 94%

The House vote on H.R. 1628, the American Health Care Act, passed 217-213. The Clerk lists Brett Guthrie, Republican of Kentucky, voting Aye.

Guthrie supported a concrete House-passed health care reform/repeal bill, showing substantial effort, but the bill still needed Senate passage and enactment.

unresolved later_term A for effort

Office of the Clerk, U.S. House of Representatives - Roll Call 256, H.R. 1628 American Health Care Act
secondary · model gpt-5.5 · confidence 95%

The Senate vote on McConnell Amendment No. 667 to H.R. 1628, the American Health Care Act of 2017, resulted in Amendment Rejected, with 49 Yeas and 51 Nays.

The 2017 repeal-and-replace effort associated with H.R. 1628 failed in the Senate, so it did not deliver a completed health care system reform despite House action.

never later_term A for effort

U.S. Senate Roll Call Vote 179, 115th Congress, 1st Session
secondary · model gpt-5.5 · confidence 94%

The Energy and Commerce Committee report says H.R. 5663, the Safeguarding Therapeutics Act, was introduced on January 21, 2020, by Representatives Brett Guthrie and Eliot Engel and would extend FDA administrative destruction authority to medical devices.

Guthrie introduced a specific health-related reform bill affecting FDA authority over counterfeit medical devices, showing concrete legislative action.

partial later_term A for effort

House Report 116-512 - Safeguarding Therapeutics Act
secondary · model gpt-5.5 · confidence 92%

Public Law 116-304 amended the Federal Food, Drug, and Cosmetic Act to authorize destruction of counterfeit devices and was approved January 5, 2021.

A Guthrie-introduced health product safety bill became law, which is a delivered health-related reform, but it is narrow and does not amount to broad health care system reform.

partial later_term A for effort

Public Law 116-304 - Safeguarding Therapeutics Act
secondary · model gpt-5.5 · confidence 93%

Public Law 115-271 states that the SUPPORT for Patients and Communities Act was enacted to provide for opioid use disorder prevention, recovery, and treatment, including Medicaid, Medicare, FDA, controlled-substance, and public health provisions.

Congress enacted a broad opioid and substance-use health law during Guthrie's later House service. This supports only partial fulfillment because it reforms parts of health care, not the overall system, and the cited law does not by itself establish Guthrie as principal sponsor.

partial later_term

Public Law 115-271 - SUPPORT for Patients and Communities Act
secondary · model gpt-5.5 · confidence 78%

The Health Subcommittee held a hearing on health care transparency and discussed an updated Lower Costs, More Transparency Act and prior-authorization data requirements.

As committee chair, Guthrie's committee continued advancing health care transparency proposals in 2026, showing ongoing effort but not enacted reform as of the evidence date.

unresolved later_term A for effort

House Committee on Energy and Commerce
secondary · model gpt-5.5 · confidence 84%

Guthrie and other Energy and Commerce leaders asked NIH for details about alleged illegal transport of biological materials and requested a written response by June 30.

This is health-related oversight activity in Guthrie's committee role, but it does not prove a completed reform of the health care system.

unresolved later_term A for effort

House Committee on Energy and Commerce
secondary · model gpt-5.5 · confidence 72%